CD45RA+ Depleted Lymphocyte Infusion for Treatment of Refractory Cytomegalovirus Disease in Complete DiGeorge Syndrome: A Case Report
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Complete DiGeorge syndrome (cDGS) refers to DGS with profound T cell deficiency. Herein, we present the case of an infant with cDGS suffering from refractory cytomegalovirus (CMV) infection and who was treated with CD45RA+ depleted lymphocyte infusion. The patient was diagnosed with cDGS by fluorescence in situ hybridization which verified 22q11.2 deletion and as well as by the observed profound T cell deficiency (CD3+ T cells 69/μL, CD4+ T cells 7/μL). On the 45th day of age, CMV viremia was first detected with a plasma viral load (VL) of 120,000 IU/mL. Ganciclovir treatment effectively reduced VL post 56 days of treatment; however, VL subsequently rebounded. A CMV UL97 phosphotransferase M460V mutation conferring ganciclovir resistance emerged and foscarnet was incorporated. Despite this, high titers of CMV viremia (VL 2,820,000 IU/mL) and CMV retinitis were complicated. To restore T cell immunity and treat refractory CMV infection, CD45RA+ depleted CMV-specific lymphocytes from the patient’s father were infused twice on the 196th and 207th days after birth. After receiving the second infusion, a decline in CMV VL was observed, with a decrease to 87,100 IU/mL by the tenth day following infusion, despite the failure in maintaining T cell increase. The patient died of Pneumocystis jirovecii pneumonia and Elizabethkingia meningoseptica sepsis on the 222nd day after birth. CD45RA+ depleted lymphocyte infusion may be a therapeutic option for refractory CMV disease in cDGS patients.
Abstract
Complete DiGeorge syndrome (cDGS) refers to DGS with profound T cell deficiency. Herein, we present the case of an infant with cDGS suffering from refractory cytomegalovirus (CMV) infection and who was treated with CD45RA+ depleted lymphocyte infusion. The patient was diagnosed with cDGS by fluorescence in situ hybridization which verified 22q11.2 deletion and as well as by the observed profound T cell deficiency (CD3+ T cells 69/μL, CD4+ T cells 7/μL). On the 45th day of age, CMV viremia was first detected with a plasma viral load (VL) of 120,000 IU/mL. Ganciclovir treatment effectively reduced VL post 56 days of treatment; however, VL subsequently rebounded. A CMV UL97 phosphotransferase M460V mutation conferring ganciclovir resistance emerged and foscarnet was incorporated. Despite this, high titers of CMV viremia (VL 2,820,000 IU/mL) and CMV retinitis were complicated. To restore T cell immunity and treat refractory CMV infection, CD45RA+ depleted CMV-specific lymphocytes from the patient’s father were infused twice on the 196th and 207th days after birth. After receiving the second infusion, a decline in CMV VL was observed, with a decrease to 87,100 IU/mL by the tenth day following infusion, despite the failure in maintaining T cell increase. The patient died of Pneumocystis jirovecii pneumonia and Elizabethkingia meningoseptica sepsis on the 222nd day after birth. CD45RA+ depleted lymphocyte infusion may be a therapeutic option for refractory CMV disease in cDGS patients.
참고문헌 (18)
- McDonald-McGinn DM, "Chromosome 22q11. 2 deletion syndrome(DiGeorge syndrome", velocardiofacial syndrome), 2011, pp.90, 1~18
- Davies EG, "Immunodeficiency in DiGeorge syndrome and options for treating cases with complete athymia", Front Immunol, 4, pp.322~ (2013)
- Markert ML, "Thymus transplantation in complete DiGeorge syndrome : immunologic and safety evaluations in 12 patients", Blood, 102, pp.1121~1130 (2003)
- Markert ML, "Review of 54 patients with complete DiGeorge anomaly enrolled in protocols for thymus transplantation : outcome of 44 consecutive transplants", Blood, 109, pp.4539~4547 (2007)
- Land MH, "Long-term results of bone marrow transplantation in complete DiGeorge syndrome", J Allergy Clin Immunol, 120, pp.908~915 (2007)
- Janda A, "Multicenter survey on the outcome of transplantation of hematopoietic cells in patients with the complete form of DiGeorge anomaly", Blood, 116, pp.2229~2236 (2010)
- Chitty-Lopez M, "Case report : unmanipulated matched sibling donor hematopoietic cell transplantation in TBX1 congenital athymia : a lifesaving therapeutic approach when facing a systemic viral infection", Front Immunol, 12, pp.721917~ (2022)
- Brodszki N, "Novel treatment of severe combined immunodeficiency utilizing ex-vivo T-cell depleted haploidentical hematopoietic stem cell transplantation and CD45RA+ depleted donor lymphocyte infusions", Orphanet J Rare Dis, 11, pp.5~ (2016)
- Hosaka S, "Establishment of immunity against Epstein-Barr virus infection in a patient with CHARGE", complete DiGeorge syndrome after peripheral blood lymphocyte transfusion, 2019, pp.23, e13424~
- Ip W, "22q11. 2 deletion syndrome with life-threatening adenovirus infection", J Pediatr, 163, pp.908~910 (2013)
- Park HJ, "Successful treatment of refractory CMV colitis after haploidentical HSCT with post-transplant cyclophosphamide using CD45RA+ depleted donor lymphocyte infusion", Bone Marrow Transplant, 55, pp.1674~1676 (2020)
- Bensoussan D, "T-cell immune constitution after peripheral blood mononuclear cell transplantation in complete DiGeorge syndrome", Br J Haematol, 117, pp.899~906 (2002)
- Janda A, "Unrelated partially matched lymphocyte infusions in a patient with complete DiGeorge", CHARGE syndrome, 2007, pp.11, 441~447
- Daguindau N, "Immune constitution monitoring after PBMC transplantation in complete DiGeorge syndrome : an eight-year follow-up", Clin Immunol, 128, pp.164~171 (2008)
- Davies EG, "Thymus transplantation for complete DiGeorge syndrome : European experience", J Allergy Clin Immunol, 140, pp.1660~1670 (2017)[DOI]
- Ohtsuka Y, "Successful engraftment and decrease of cytomegalovirus load after cord blood stem cell transplantation in a patient with DiGeorge syndrome", Eur J Pediatr, 163, pp.747~748 (2004)
- Gul KA, "Neonatal levels of T-cell receptor excision circles(TREC)in patients with 22q11. 2 deletion syndrome and later disease features", J Clin Immunol, 35, pp.408~415 (2015)
- Amatuni GS, "Newborn screening for severe combined immunodeficiency and T-cell lymphopenia in California, 2010-2017", Pediatrics, 143, pp.143~ (2019)